The best indicator for Moody's Corporation (MCO)
We backtested 20 indicators across daily, weekly and hourly charts on real Moody's Corporation (MCO) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
RSI Trend (>50)
On the weekly chart, this is the strongest risk-adjusted edge we found for Moody's Corporation (MCO) over ~31.7 years — trailing buy-and-hold by 4.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | RSI Trend (>50) ✓ | Weekly | 10.2% | 0.57 | -40.2% | 53.7% | 67 | -4.2% |
| 2 | EMA 50/200 Cross ✓ | Daily | 10.5% | 0.55 | -54.5% | 47.1% | 17 | -3.9% |
| 3 | Rate of Change ✓ | Weekly | 7.6% | 0.46 | -58.4% | 52.6% | 97 | -6.9% |
| 4 | Donchian Midline ✓ | Weekly | 7.4% | 0.46 | -48.7% | 59.3% | 86 | -7.0% |
| 5 | MACD ✓ | Weekly | 7.4% | 0.45 | -59.3% | 61.3% | 62 | -7.1% |
| 6 | ADX / DMI ✓ | Weekly | 6.5% | 0.45 | -49.6% | 55.8% | 43 | -7.9% |
| 7 | SMA 50/200 Cross ✓ | Daily | 7.6% | 0.43 | -74.4% | 54.5% | 22 | -6.8% |
| 8 | EMA 20/50 Cross ✓ | Daily | 7.4% | 0.43 | -69.0% | 45.7% | 70 | -7.1% |
| 9 | EMA 20/50 Cross ✓ | Weekly | 12.9% | 0.64 | -44.8% | 60.0% | 10 | -1.5% |
| 10 | Donchian Breakout ✓ | Weekly | 6.4% | 0.42 | -66.8% | 65.4% | 26 | -8.0% |
| 11 | Bollinger Breakout ✓ | Weekly | 5.0% | 0.39 | -39.1% | 66.7% | 33 | -9.4% |
| 12 | CCI ✓ | Daily | 6.0% | 0.37 | -68.5% | 74.1% | 147 | -8.4% |
| 13 | Holy Grail Confluence ✓ | Daily | 5.0% | 0.34 | -45.6% | 72.5% | 40 | -9.5% |
| 14 | Heikin-Ashi Trend ✓ | Weekly | 5.2% | 0.34 | -41.9% | 49.5% | 291 | -9.3% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Moody's Corporation (MCO), RSI Trend (>50) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.